Duke professor's research leads to first drug for type of liver disease
By Ahilan Eraniyan | YesterdayThe drug, resmetirom, is a novel treatment for metabolic dysfunction-associated steatohepatitis (MASH), a common nonalcoholic liver disease linked to obesity.